Amdocs director Eliahu Meir Gelman receives 10,810 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Amdocs Ltd. director Eliahu Meir Gelman acquired 10,810 ordinary shares in a grant on November 9, 2026. His directly held position following the award was 350,946 ordinary shares.
Insider Trade Summary
Grant/Award: 10,810 shares
Grant/Award
1 txn
Insider
Gelman Eliahu Meir
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares | 10,810 | $0.00 | $0.00 |
Holdings After Transaction:
Ordinary Shares — 350,946 shares (Direct)
Holdings Before and After:
Ordinary Shares, 340,136 to 350,946 shares (Direct)
Key Figures
Shares granted: 10,810 shares
Direct holdings after grant: 350,946 shares
2 metrics
Shares granted
10,810 shares
Grant to director Eliahu Meir Gelman on November 9, 2026
Direct holdings after grant
350,946 shares
Eliahu Meir Gelman's reported ordinary shares following the grant
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.